1 / 31

SEMINAR ON POLYMORPHISM (As a part of Preformulation )

SEMINAR ON POLYMORPHISM (As a part of Preformulation ). CONTENTS:. Definition Need to study polymorphism Properties Types of polymorphism How to differentiate them Pseudopolymorphism Methods to identify polymorphism Parameters to be cared by preformulator

amaris
Download Presentation

SEMINAR ON POLYMORPHISM (As a part of Preformulation )

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SEMINAR ON POLYMORPHISM (As a part of Preformulation) Paper 910101 (2009-2010)

  2. CONTENTS: • Definition • Need to study polymorphism • Properties • Types of polymorphism • How to differentiate them • Pseudopolymorphism • Methods to identify polymorphism • Parameters to be cared by preformulator • Solubility, dissolution behaviour and bioavailability of polymorph • Factor affecting polymorphism • Effect of polymorphism on bioavailability • Conclusion • References Paper 910101 (2009-2010)

  3. THUS IT IS DEFINED AS THE ABILITY OF SUBSTANCE TO EXIST AS TWO OR MORE CRYSTALLINE PHASES THAT HAVE DIFFERENT ARRRANGEMENTS OR CONFIRMATIONS OF THE MOLECULES IN THE CRYSTAL LATTICE. Elements can exist in two or more different forms, known as allotropes of that element. Eg. Carbon : diamond in cubic( tetrahedral lattice arrangement) graphite in sheets of a hexagonal lattice Similar phenomenon in compounds, scientifically referred to as polymorphismThe term polymorphism was coined by AGUIAR ETAL in 1967 Paper 910101 (2009-2010)

  4. STABILITY CHARECTERISTICS Depending upon relative stability there are two forms of polymorphs. a) stable form having lowest energy state, highest melting point and least aqueous solubility. b) Metastable form having higher energy state, lower melting point and higher aqueous solubility. OSTWALD RULE OF STAGES (STEP RULE) Statement :- It is not the most stable state with the lowest amount of free energy that is initially formed but the least stable lying nearest in free energy to the original state Paper 910101 (2009-2010)

  5. NEED TO STUDY POLYMORPHISM • Polymorphism is remarkably common particularly within certain structural groups. For eg. • They may interact differently with different formulation excipients/processes. Paper 910101 (2009-2010)

  6. NEED TO STUDY POLYMORPHISM • The effect of polymorphism on bioavailability is the most important consequence for drug substances if the bioavailability is mediated via dissolution. • Examples:- chloramphenicol palmitate noviobiocine griseofulvine Carbamazepine aspirin ampicilline • The polymorphism of the excipients may also play an important role in bioavailability. • Polymorphic behavior of drugs and excipients is an important part of the preformulation work Paper 910101 (2009-2010)

  7. PROPERTIES • Show the same properties in liquid or gaseous state but they behave differently in solid state. • Differ from each other with respect to physical properties like • Melting and sublimation temperature • Vapour pressure • Solubility and dissolution rate • Stability • Optical and electrical properties • Crystal habit • Hygroscopicity • Heat capacity • Solid –state reactions • Conductivity • Compression characteristics Paper 910101 (2009-2010)

  8. TYPES: • PHASE TRANSITION: process of transformation of one polymorph into another, which may also occur on storage or during processing is called phase transition. • TRANSITION TEMPERATURE: Temperature at which both stable and metastable forms exist in equilibrium with each other. • ENANTIOTROPS: If one form stable over certain pressure and temperature range, while the other polymorph is stable over different pressure and temperature range.eg,sulfur • MONOTROPS: only one polymorph is stable at all temperature below the melting point, with all other polymorph being unstable. glyceryl stearate,chloramphenicol palmitate. • Enantiotrope and monotrope are differentiated by vapor pressure versus temperature curve and solubility versus temp curve Paper 910101 (2009-2010)

  9. DIFFERENCE BETWEEN ENANTIOTROPY AND MONOTROPY • Enantiotropic pair • Reversible phase transition • metastable ↔ stable • lower melting form is thermodynamically stable below the transition temperature and higher melting form is stable above the transition temperature • Transition is endothermic (heat of fusion rule) • Higher m.p. has lower heat of fusion • Affected by temp. moisture and grinding • Monotopic pair • Irreversible phase transition • Metastable →stable • higher melting form is always thermodynamically stable form • Transition is exothermic (heat of fusion rule) • Higher m.p. has higher heat of fusion • Not affected by temp. moisture and grinding Paper 910101 (2009-2010)

  10. VAPOR PRESSURE DIAGRAM OF AN ENANTIOTROPIC PAIR Vapor pressure Temperature C Paper 910101 (2009-2010)

  11. VAPOR PRESSURE DIAGRAM OF MONOTROPIC PAIR Vapor pressure Temperature C Paper 910101 (2009-2010)

  12. PSEUDOPOLYMORPHISM • The term pseudo means false. • Phenomenon in which solvent molecules get incorporated into crystal lattice of solid are known as solvates. These solvates exist in different crystal form called pseudo polymorphs and the phenomenon is called as pseudopolymorphism. • Also known as hydrates when water is solvent. • E.g.1) theophylline monohydrate 2) ampicilline trihydrate Paper 910101 (2009-2010)

  13. HOW TO DIFFERENTIATE PSEUDOPOLYMORPHS FROM TRUE POLYMORPHS? • Melting behavior in silicon oil using HOT STAGE MICROSCOPY. • Pseudopolymorphs evolve gas (steam or solvent vapors) causing bubbling of the oil. • True polymorphs merely melts, forming second globular phase. Paper 910101 (2009-2010)

  14. METHODS TO IDENTIFY POLYMORPHISM • Optical crystallography • Hot stage microscopy • X-ray diffraction method • NMR technique • FTIR • Dilatometry • Microcalorimetry • Thermal methods A) DSC [Differential Scanning Calorimetry] B) DTA [Differential Thermal Analysis] C) TGA [Thermal Gravimetric Analysis] Measures heat loss or gain from physical or chemical changes occurring in sample which is recorded as a function of temperature. • Melting point determination Paper 910101 (2009-2010)

  15. PARAMETERS TO BE CARED BY PREFORMULATOR • No of polymorphs • Relative degree of stability • Presence of glassy state • Stabilization of metastable form • Temperature stability range • Solubility of each • Method of preparation • Effect of micronization • Excipient incompatibility Paper 910101 (2009-2010)

  16. RELATIVE SOLUBILITY OF POLYMORPH • In order to assess the relative increase in solubility of polymorphs with respect to another, a simple solubility ratio can be defined:- • Solubility ratio = solubility of metastable form solubility of stable form • From following table, we can say that solubility ratio is higher than one just because of relative higher solubility of metastable form, which leads to increase in apparent solubility. Paper 910101 (2009-2010)

  17. Paper 910101 (2009-2010)

  18. DISSOLUTION BEHAVIOUR OF POLYMORPH • The absorption rate and bioavailability of drug administered orally is controlled by many factors among which dissolution rate is one of the most important. • Therefore physicochemical state such as polymorphism or amorphism of drugs affect bioavailability of pharmaceutical preparation. • Amorphous>metastable> stable • eg. Chemical incompatibility between ß lactum antibiotics and water is reduced through crystallization. Paper 910101 (2009-2010)

  19. EFFECT OF POLYMORPHISM ON BIOAVAILABILITY • If the absorption of active ingredient in drug through G.I.T. is dissolution rate dependent then polymorphism is an important preformulation tool. • Here successful utilization of polymorph having significant greater thermodynamic activity (solubiity)may provide good therapeutic blood level from otherwise inactive drugs • eg. Ritonavir form I is more soluble form and form II is thermodynamically stable and much less soluble than form I which affects its bioavailabilty. Paper 910101 (2009-2010)

  20. STABILITY OF METASTABLE POLYMORPH • The difference in melting point (Δmp) between polymorphs is measure of the metastable polymorph stability. • If Δmp<1oc neither is significantally more stable. • If Δmp= 25-500c lower melting species will be difficult to crystallize and will revert rapidly. • If Δmp= 1-250c unstable form can be obtained easily before solid-solid transition. Paper 910101 (2009-2010)

  21. FACTOR AFFECTING POLYMORPHISM (A)Temperature and humidity:- • Storage conditions affect physicochemical reactions which are accelerated at higher temperature(Arhenious theory). • Humidity act as catalyst on the solid surface. Therefore both are the important factors for the prefomulator scientist to consider. • eg.Chlortetracycline hydrochloride has two different polymorphs form:α and ß. Alpha form is stable up to 82% RH while beta form is hygroscopic. Paper 910101 (2009-2010)

  22. Effect of humidity and temperature • Zanoterone: The solid-state degradation rate of form IV (hemihydrate A) is found to be greater than that of form III at 40°C/25% RH and 40°C/75% RH. At 40°C/75% RH, the rate of degradation is 4-fold higher for form IV vs. form II. • Polymorphic transformation of phenylbutazone and cocoa butter occur after heating • Recent studies done on paracetamol.It consist of form-1 (monoclinic) and form-2 (orthorhombic) At high temp(500k)form-II is stable • Leflunomide Form I and Form II.Here Form I : Stable below transition temperature. (127c) Paper 910101 (2009-2010)

  23. (B) Photostability • Photostability of two polymorphs of tamoxifen citrate upon irradiation by visible light and u.v. light investigated using chromatography and spectroscopy. The surface color of pellets prepared with either crystal forms turned from white to brown but the extent of the color change in cross section of form –A pellets was deeper than that of form –B pellets. So form A exhibit higher degree of Photo-instability relative to that of form B. • Acetametacin: ,  :- Stable and :- Unstable Paper 910101 (2009-2010)

  24. Effect of solvent • Solvent can bring dramatic change in growth mechanism and morphology. Growth kinetic of crystal growing from solution was determined by two important factors. • Degree of molecular roughness. • Nature of absorption of the solvent from surface. Paper 910101 (2009-2010)

  25. (D) Effect of grinding • Grinding process reduce particle size ,so increasing specific surface area and that’why direct effect on dissolution rate and bioavaibility of the preparation. During grinding process solid state polymorphic transformation in to non-crystalline or metastable form is caused by mechanical action. • eg. Prasterone sulfate dihydrate • Here dihydrate form is more stable than anhydrous form. with increasing grinding time compound become unstable because grinding weakened bonding crystals and water molecules participating in hydrolysis process of the drug. • The grinding process can easily induce the polymorphic transition of famotidine from form B to form A and this was accelerated by thermal effect. Paper 910101 (2009-2010)

  26. (E) Effect of tablet compression • The mechanical stability and compaction behaviour of the polymorphic form of drug during tableting are very important in practice. • Eg.Polymorphic transformation of phenylbutazone in which form III is converted to form II at > 2000kg/cm2. • barbital metastable :Form IIstable Form I Solubility changes of tablet due to phase transformation. Paper 910101 (2009-2010)

  27. High throughput crystallization technique • high-throughput (HT) crystallization systems uses a combinatorial approach to solid form generation, where large arrays of conditions and compositions are processed in parallel. • Screen 1000’s of crystallization conditions • Small amount of API • Variety of solvents, additives, conditions necessarily generates large set of data. • Solid form discovery in highly polymorphic form. • A fully integrated HT crystallization system consists of experimental design and execution software, robotic dispensing and handling hardware, automated high-speed micro-analytical tools, integrated cheminformatics analysis software Paper 910101 (2009-2010)

  28. CONCLUSION • If it appears that polymorphism is occurring or is likely to occur in the samples supplied for preformulation work then a cooperative study with the bulk chemists should determine the most stable form chemically and physically. • Difference in the solubility and melting point must also be assessed and then a decision can be made to determine which form to progress through to the next stage of formulation. • Small difference in the stability but higher solubility of a relatively metastable form may lead to a preferential choice of a polymorph other than stable form but suspension systems should never be made with a metastable form. Paper 910101 (2009-2010)

  29. REFERENCES • Biopharmaceutics and pharmacokinetics. By – D.M.Brahmankar, Sunil Jaiswal • The theory and practice of industrial pharmacy. By - Leon Lechman, Joseph L Kanig • Physical pharmacy. By –Alfred Martin • Pharmaceutics :-The science of dosage from design, By - Michael E Aulton. • Ansels pharmaceutical dosage form and drug delivery system VIII edition. • Remington the science and practice of pharmacy. • Drug stability second edition by Jens T carstensen • Polymorphism in pharmaceutical solids, Harry G. Brittain. Paper 910101 (2009-2010)

  30. Chemical abstract vol-146 no-8 2007 Chemical abstract vol-147 no-12 2007 Chemical abstract vol-147 no-16 2007 Chemical abstract vol-147 no-18 2007 Chemical abstract vol-150 no-14 2009 Chemical abstract vol-150 no-26 2009 JPS (98,No.5) 2009 REFERENCE Paper 910101 (2009-2010)

  31. THANKS Paper 910101 (2009-2010)

More Related